ArticleChildren (Basel, Switzerland)2022

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022.

Laura Torres-Canchala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.